Noonan syndrome with multiple lentigines: genes and variants
Explore variant evidence for Noonan syndrome with multiple lentigines across 3 analyzed proteins (PTPN11, BRAF, MAP2K1). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Noonan syndrome with multiple lentigines
PTPN11: Tyrosine-protein phosphatase non-receptor type 11
Its SHP2 phosphatase activity promotes RAS-MAPK signaling downstream of many receptor tyrosine kinases and cytokine receptors. Germline dysregulating variants cause Noonan-spectrum disorders, while somatic activating variants drive juvenile myelomonocytic leukemia and other cancers.
4 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTPN11 have source records linked to Noonan syndrome with multiple lentigines. Association strength is not clinical gene validity.
BRAF: Serine/threonine-protein kinase B-raf
It relays activated RAS signals through MEK and ERK to control proliferation, differentiation, and survival. Activating variants, especially V600E, drive melanoma and several other cancers and create sensitivity to pathway-directed therapies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BRAF have source records linked to Noonan syndrome with multiple lentigines. Association strength is not clinical gene validity.
MAP2K1: Dual specificity mitogen-activated protein kinase kinase 1
It phosphorylates ERK1 and ERK2 downstream of RAF and thereby propagates RAS-MAPK growth and developmental signals. Activating somatic variants occur in several cancers, while germline activating variants can cause cardio-facio-cutaneous syndrome and related RASopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MAP2K1 have source records linked to Noonan syndrome with multiple lentigines. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): RAF1.
ClinVar pathogenic and likely pathogenic variants linked to Noonan syndrome with multiple lentigines
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PTPN11 T468M | 468 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★★) |
| PTPN11 Q510P | 510 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★★) |
| PTPN11 Q256R | 256 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 R498L | 498 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- RASopathy also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Noonan syndrome with multiple lentigines variants (51 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Noonan syndrome with multiple lentigines variants (44 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Noonan syndrome with multiple lentigines variants (29 pathogenic / likely pathogenic).
- LEOPARD syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Noonan syndrome with multiple lentigines variants (16 pathogenic / likely pathogenic).
- Metachondromatosis also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Noonan syndrome with multiple lentigines variants (11 pathogenic / likely pathogenic).
Diseases related to Noonan syndrome with multiple lentigines
- RASopathy, also linked to BRAF, MAP2K1 and PTPN11
- Noonan syndrome, also linked to BRAF, MAP2K1 and PTPN11
- Noonan syndrome and Noonan-related syndrome, also linked to BRAF, MAP2K1 and PTPN11
- Hypertrophic cardiomyopathy, also linked to BRAF and MAP2K1
- Cardiofaciocutaneous syndrome, also linked to BRAF and MAP2K1
- Cardio-facio-cutaneous syndrome, also linked to BRAF and MAP2K1
- LEOPARD syndrome, also linked to BRAF and PTPN11
- Non-small cell lung carcinoma, also linked to BRAF and MAP2K1
- Costello syndrome, also linked to BRAF and MAP2K1
- Vascular malformation, also linked to BRAF and MAP2K1
- Male infertility with azoospermia or oligozoospermia due to single gene mutation, also linked to MAP2K1 and PTPN11
- Melanoma, also linked to BRAF and MAP2K1
Frequently asked questions
Which genes have records linked to Noonan syndrome with multiple lentigines?
This view contains 3 analyzed proteins: PTPN11, BRAF, MAP2K1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 14 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center